Tiny Michigan biotech startup CircNova has raised a $3.3 million seed round for its technology that uses AI to target so-called “circular RNA.” The development holds promise as a new method to quickly develop therapies for conditions that currently have no drug treatments. The new funding is also a victory lap for co-founder and CEO…
Category: biotechnology
biomanufacturing, biosphere, Biotech & Health, biotechnology, Climate, electrification, Exclusive, Fundraising, Global IT News, Global Security News, Lowercarbon Capital, VXI Capital
Biosphere zaps germs with UV light to make biomanufacturing cheaper
Using LEDs has the potential to bring down the cost of biomanufacturing, allowing such processes to make materials that previously would have been too expensive. © 2024 TechCrunch. All rights reserved. For personal use only.